Trial Profile
Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cicletanine (Primary)
- Indications Hypertension in diabetes; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms CHAMP
- Sponsors Navitas Pharma
- 30 Aug 2021 Planned End Date changed from 1 Sep 2017 to 1 Sep 2024.
- 30 Aug 2021 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2024.
- 30 Aug 2021 Planned initiation date changed from 1 Jun 2016 to 1 Jun 2022.